From sky to pale ice, the fashion insider-approved shade has been seen all over the runway ...
The Oscar-nominated actress uses a pale pink sofa to bring brightness and fun to her monochromatic living room – it's a ...
Nike is continuing to shine a light on its legendary Tuned Air technology with the upcoming release of the Nike Air Max Plus “Black/Blue Crystal.” Arriving in 2026, the new iteration brings a moody ...
A trusty pair of dark-wash jeans is a wardrobe essential—a lesson I unfortunately learned the hard way when I was left with a profound gap in my closet after I outgrew my favorite pair. Once I ...
The U.S. Air Force is repainting Air Force One and other aircraft in the presidential and executive fleet in President Donald Trump’s preferred red, white and dark blue color palette — replacing the ...
The new album from the Sturgill Simpson project is set to release March 13. By Jessica Nicholson Johnny Blue Skies & the Dark Clouds are bringing new music to the fans, with the upcoming release of ...
The album from the iconoclastic artist will only be available on vinyl, CD and cassette, a strategy virtually unheard of for a new release from a major artist outside the realm of Record Store Day ...
Subscribe to Marlin magazine and get a year of highly collectible, keepsake editions – plus access to the digital edition and archives. Sign up for the free Marlin email newsletter. There’s no place ...
This is read by an automated voice. Please report any issues or inconsistencies here. Amgen, a Thousand Oaks-based biotechnology giant, has acquired Dark Blue Therapeutics Ltd., a privately held ...
Amgen AMGN announced that it has acquired U.K.-based private biotech company, Dark Blue Therapeutics, for approximately $840 million. The acquisition will strengthen Amgen’s oncology pipeline by ...
Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The California pharma has stitched together a deal worth up to $840 ...
Amgen has acquired U.K.-based biotechnology company Dark Blue Therapeutics in a transaction valued at up to $840 million. Amgen on Tuesday said the deal adds an investigational small molecule that ...